Treatment outcomes of multidrug-resistant tuberculosis patients receiving ambulatory treatment in Shenzhen, China: a retrospective cohort study

BACKGROUND: WHO recommended multidrug-resistant tuberculosis (MDR-TB) should be treated mainly under ambulatory model, but outcome of ambulatory treatment of MDR-TB in China was little known. METHODS: The clinical data of 261 MDR-TB patients treated as outpatients in Shenzhen, China during 2010–2015...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecai, Ji, Mijiti, Peierdun, Chuangyue, Hong, Qian, Gao, Weiguo, Tan, Jihong, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319049/
https://www.ncbi.nlm.nih.gov/pubmed/37408751
http://dx.doi.org/10.3389/fpubh.2023.1134938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319049/
https://www.ncbi.nlm.nih.gov/pubmed/37408751
http://dx.doi.org/10.3389/fpubh.2023.1134938

Ejemplares similares